The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
De-escalated neoadjuvant pertuzumab+trastuzumab with or without paclitaxel weekly in HR-/HER2+ early breast cancer: ADAPT-HR-/HER2+ biomarker and survival results.
 
Nadia Harbeck
No Relationships to Disclose
 
Oleg Gluz
No Relationships to Disclose
 
Matthias Christgen
No Relationships to Disclose
 
Sherko Kuemmel
No Relationships to Disclose
 
Eva-Maria Grischke
No Relationships to Disclose
 
Michael Braun
No Relationships to Disclose
 
Jochem Potenberg
No Relationships to Disclose
 
Katja Krauss
No Relationships to Disclose
 
Claudia Schumacher
No Relationships to Disclose
 
Helmut Forstbauer
No Relationships to Disclose
 
Toralf Reimer
No Relationships to Disclose
 
Andrea Stefek
No Relationships to Disclose
 
Hans Holger Fischer
No Relationships to Disclose
 
Enrico Pelz
No Relationships to Disclose
 
Monika Graeser
No Relationships to Disclose
 
Christine zu Eulenburg
No Relationships to Disclose
 
Ronald E. Kates
No Relationships to Disclose
 
Rachel Wuerstlein
No Relationships to Disclose
 
Hans Heinrich Kreipe
No Relationships to Disclose
 
Ulrike Nitz
No Relationships to Disclose